BIAF Stock: bioAffinity Technologies, Inc. Stock Price, Analysis & Insights

Get live BIAF stock price $1.54, comprehensive bioAffinity Technologies, Inc. stock analysis, charts, news, and expert forecast. Real-time BIAF stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

1.54

1.98%Today

BIAF • bioAffinity Technologies, Inc. • NASDAQ Capital Market • Healthcare

Market Cap

6.98M

Volume

15.99K

52W High

13.80

52W Low

0.69

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the ...

Contact Information

Website: https://www.bioaffinitytech.com
Address: 22211 West Interstate 10
Country: US

Investment Analysis & Business Insights

Healthcare

Medical - Diagnostics & Research

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -1.33) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for bioAffinity Technologies, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for bioAffinity Technologies, Inc.
⚠Investors should consider how bioAffinity Technologies, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

6.98M

P/E Ratio (TTM)

-0.33

Beta

-1.33

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare BIAF with peer companies:

Artelo Biosciences, Inc. (ARTL)

Price: $1.35
Market cap: 3.15M

Carisma Therapeutics, Inc. (CARM)

Price: $0.00
Market cap: 66.95K

GT Biopharma, Inc. (GTBP)

Price: $0.43
Market cap: 4.51M

Lipella Pharmaceuticals Inc. (LIPO)

Price: $0.08
Market cap: 369.67K

Mobile-health Network Solutions Class A Ordinary Shares (MNDR)

Price: $0.71
Market cap: 627.74K

Psyence Biomedical Ltd. (PBM)

Price: $3.32
Market cap: 63.23K

Protagenic Therapeutics, Inc. (PTIX)

Price: $0.54
Market cap: 977.51K

Revelation Biosciences, Inc. (REVB)

Price: $1.03
Market cap: 4.03M

Salarius Pharmaceuticals, Inc. (SLRX)

Price: $0.84
Market cap: 4.92M

WORK Medical Technology Group Ltd. (WOK)

Price: $0.10
Market cap: 570

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.